BMLL — Bio Medica Laboratories Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹1.54bn
- IN₹1.69bn
- IN₹381.95m
Annual cashflow statement for Bio Medica Laboratories, fiscal year end - March 31st, millions except per share.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ||
| Standards: | — | — | IAS | IAS | IAS |
| Status: | fx Preliminary | fx Preliminary | Final | Final | Final |
| Net Income/Starting Line | — | — | 4.52 | 36.5 | 131 |
| Depreciation | |||||
| Non-Cash Items | — | — | -2.68 | -0.079 | -0.02 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | — | — | 16.1 | -31.3 | -178 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | — | — | 22.9 | 16.2 | -36.7 |
| Capital Expenditures | — | — | -17.1 | -15.3 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | 0.199 | -0.118 | 3.39 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | — | — | -16.9 | -15.4 | 3.39 |
| Financing Cash Flow Items | — | — | -7.71 | -9.66 | -11.9 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | — | — | -21.3 | -0.825 | 33.3 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | — | — | -15.2 | 0.041 | -0.035 |